1-2 of 2
Colleen Callahan, MSN, CRNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy

Vijay Bhoj, MD PhD, Michael C Milone, MD PhD, Carl H. June, MD, David Porter, MD, Stephan A. Grupp, MD PhD, Jan J Melenhorst, PhD, Simon F. Lacey, PhD BSc, Colleen Callahan, MSN, CRNP, James Capobianchi, Gerald Wertheim, MDPhD, Yolanda Mahnke, PhD
Journal: Blood
Blood (2014) 124 (21): 1110.
https://doi.org/10.1182/blood.V124.21.1110.1110
Published: 2014
Journal Articles

T Cells Engineered with a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MDPhD, Colleen Callahan, MSN, CRNP, Anne Chew, PhD, Simon F. Lacey, PhD BSc, Bruce L. Levine, PhD, J. Joseph Melenhorst, PhD, Laura Motley, RN, BSN, Susan R. Rheingold, MD, Angela Shen, MD, David T. Teachey, MD, Patricia A. Wood, MD PhD, David L Porter, MD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 380.
https://doi.org/10.1182/blood.V124.21.380.380
Published: 2014